pyruvaldehyde has been researched along with linagliptin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hammes, HP; Humpert, PM; Klein, T; Lin, J; Morcos, M; Schlotterer, A; Wongchai, K | 1 |
| Doi, S; Irifuku, T; Masaki, T; Nagai, T; Nakashima, A; Sasaki, K; Ueno, T | 1 |
| Bugert, P; Busch, S; Dietrich, N; Fleming, T; Hammes, HP; Kaiser, U; Klein, T; Kolibabka, M; Lin, J; Morcos, M; Schlotterer, A | 1 |
3 other study(ies) available for pyruvaldehyde and linagliptin
| Article | Year |
|---|---|
Protective Effects of Liraglutide and Linagliptin in C. elegans as a New Model for Glucose-Induced Neurodegeneration.
Topics: Animals; Antioxidants; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Dose-Response Relationship, Drug; Forkhead Transcription Factors; Glucose; Glycation End Products, Advanced; Linagliptin; Liraglutide; Longevity; Models, Biological; Nerve Degeneration; Neuroprotective Agents; Proto-Oncogene Proteins c-akt; Pyruvaldehyde; Reactive Oxygen Species | 2016 |
Linagliptin Ameliorates Methylglyoxal-Induced Peritoneal Fibrosis in Mice.
Topics: Animals; Biomarkers; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Injections, Intraperitoneal; Linagliptin; Male; Mice; Mice, Inbred C57BL; Peritoneal Fibrosis; Pyruvaldehyde | 2016 |
The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy.
Topics: Animals; Blood Glucose; Caenorhabditis elegans; Diabetic Retinopathy; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Hypoglycemic Agents; Linagliptin; Male; Pericytes; Pyruvaldehyde; Rats; Rats, Wistar; Retinal Ganglion Cells | 2016 |